Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1 Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; 2 Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands; 3 Centre for Epidemiology and Public Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK; 4 Dundee Centre for Health and Related Research, School of Nursing and Health Sciences, University of Dundee, Dundee, UK; 5 Department of Health Sciences, University of York, York, UK; 6 Department of Medicine and Public Health Sciences, University of Chicago, Chicago, IL, USA; 7 Department of Psychiatry, UT Southwestern University, Dallas, TX, USA; 8 Departments of Psychology and Neuroscience, Bio-Imaging Research Center, University of Georgia, Athens, GA, USA; 9 Department of Psychiatry, Yale University, New Haven, CT, USA; 10Beth Israel Hospital, Harvard University, Boston, MA, USA; 11Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, OH, USA
Список исп. литературыСкрыть список 1. Carpenter WT, Bustillo JR, Thaker GK et al. The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11. Psychol Med 2009;39:2025-42. 2. Krueger RF, Eaton NR. Transdiagnostic factors of mental disorders. World Psychiatry 2015;14:27-9. 3. Krueger RF, Piasecki TM. Toward a dimensional and psychometricallyinformed approach to conceptualizing psychopathology. Behav Res Ther 2002;40:485-99. 4. Reininghaus U, Bohnke JR, Hosang G et al. Evaluation of the validity and utility of a transdiagnostic psychosis dimension encompassing schizophrenia and bipolar disorder. Br J Psychiatry 2016;209:107-13. 5. Reininghaus U, Priebe S, Bentall RP. Testing the psycho-pathology of psychosis: evidence for a general psychosis dimension. Schizophr Bull 2013;39:884-95. 6. Cuthbert BN. The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry 2014;13:28-35. 7. Borsboom D. A network theory of mental disorders. World Psychiatry 2017; 16:5-13. 8. First MB, Rebello TJ, Keeley JW et al. Do mental health professionals use diagnostic classifications the way we think they do? A global survey. World Psychiatry 2018;17:187-95. 9. Jablensky A. Psychiatric classifications: validity and utility. World Psychiatry 2016;15:26-31. 10. Kotov R, Krueger RF, Watson D. A paradigm shift in psychiatric classification: the Hierarchical Taxonomy Of Psychopathology (HiTOP). World Psychiatry 2018;17:24-5. 11. Maj M. The DSM-5 approach to psychotic disorders: is it possible to overcome the ‘inherent conservative bias’? Schizophr Res 2013;150:38-9. 12. Maj M. Narrowing the gap between ICD/DSM and RDoC constructs: possible steps and caveats. World Psychiatry 2016;15:193-4. 13. Maj M. The need for a conceptual framework in psychiatry acknowledging complexity while avoiding defeatism. World Psychiatry 2016;15:1-2. 14. Maj M. Why the clinical utility of diagnostic categories in psychiatry is intrinsically limited and how we can use new approaches to complement them. World Psychiatry 2018;17:121-2. 15. McGorry PD, Hartmann JA, Spooner R et al. Beyond the «at risk mental state» concept: transitioning to transdiagnostic psychiatry. World Psychiatry 2018;17:133-42. 16. Owen MJ, O’Donovan MC. Schizophrenia and the neurodevelopmental continuum: evidence from genomics. World Psychiatry 2017;16:227-35. 17. van Os J, Reininghaus U. Psychosis as a transdiagnostic and extended phenotype in the general population. World Psychiatry 2016;15:118-24. 18. Widiger TA. A dimensional model of psychopathology. Psychopathology 2005;38:211-4. 19. Barch DM. The neural correlates of transdiagnostic dimensions of psychopathology. Am J Psychiatry 2017;174:613-5. 20. Cuthbert BN, Insel TR. Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. Schizophr Bull 2010;36:1061-2. 21. Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 2013;11:126. 22. Tamminga CA, Ivleva EI, Keshavan MS et al. Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry 2013;170:1263-74. 23. Tamminga CA, Pearlson G, Keshavan M et al. Bipolar and schizophrenia network for intermediate phenotypes: outcomes across the psychosis continuum. Schizophr Bull 2014;40(Suppl. 2):S131-7. 24. Krueger RF, Kotov R, Watson D et al. Progress in achieving quantitative classification of psychopathology. World Psychiatry 2018;17:282-93. 25. Laursen TM, Agerbo E, Pedersen CB. Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index. J Clin Psychiatry 2009;70:1432-8. 26. Rosen C, Marvin R, Reilly JL et al. Phenomenology of first-episode psychosis in schizophrenia, bipolar disorder, and unipolar depression: a comparative analysis. Clin Schizophr Relat Psychoses 2012;6:145-51. 27. Cardno AG, Owen MJ. Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder. Schizophr Bull 2014;40:504-15. 28. Lichtenstein P, Yip BH, Björk C et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009;373:234-9. 29. Laursen TM, Munk-Olsen T, Nordentoft M et al. A comparison of selected risk factors for unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia from a Danish populationbased cohort. J Clin Psychiatry 2007;68:1673-81. 30. van Os J, Kapur S. Schizophrenia. Lancet 2009;374:635-45. 31. Russo M, Levine SZ, Demjaha A et al. Association between symptom dimensions and categorical diagnoses of psychosis: a cross-sectional and longitudinal investigation. Schizophr Bull 2014;40:111-9. 32. Clementz BA, Sweeney JA, Hamm JP et al. Identification of distinct psychosis biotypes using brain-based biomarkers. Am J Psychiatry 2016;173:373-84. 33. First MB, Spitzer RL, Gibbon M et al. Structured clinical interview for DSMIV axis I disorders – clinician version (SCID-CV). Washington: American Psychiatric Press, 1997. 34. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76. 35. Young R, Biggs J, Ziegler V et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-35. 36. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9. 37. Birchwood M, Smith J, Cochrane R et al. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry 1990;157:853-9. 38. Chalmers RP, Flora DB. Maximum-likelihood estimation of noncompensatory IRT models with the MH-RM algorithm. Appl Psychol Measur 2014;38:339-58. 39. Kass RE, Wasserman L. A reference Bayesian test for nested hypotheses and its relationship to the Schwarz criterion. J Am Stat Assoc 1995;90:928-34. 40. Gibbons RD, Hedeker DR. Full-information bi-factor analysis. Psychometrika 1992;57:423-36. 41. Peterson LE, Coleman MA. Machine learning-based receiver operating characteristic (ROC) curves for crisp and fuzzy classification of DNA microarrays in cancer research. Int J Approx Reason 2008;47:17-36. 42. StataCorp. Stata Statistical Software: release 14. StataCorp, LP, 2015. 43. Lahey BB, Krueger RF, Rathouz PJ et al. Validity and utility of the general factor of psychopathology. World Psychiatry 2017;16:142-3. 44. Kirkbride JB, Hindocha C, Hameed Y et al. Do symptom dimensions vary between ethnic groups at first presentation to early intervention in psychosis services? Evidence from the SEPEA study. Early Interv Psychiatry 2016;10(Suppl. 1):15-6. 45. Veling W, Selten JP, Mackenbach JP et al. Symptoms at first contact for psychotic disorder: comparison between native Dutch and ethnic minorities. Schizophr Res 2007;95:30-8. 46. Cantor-Graae E, Selten JP. Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry 2005;162:12-24. 47. Reininghaus U, Craig TK, Fisher HL et al. Ethnic identity, perceptions of disadvantage, and psychosis: findings from the AESOP study. Schizophr Res 2010;124:43-8. 48. Reininghaus U, Morgan C, Simpson J et al. Unemployment, social isolation, achievement-expectation mismatch and psychosis: findings from the AESOP Study. Soc Psychiatry Psychiatr Epidemiol 2008;43:743-51. 49. van Os J, Reininghaus U. The clinical epidemiology of schizophrenia. In: Sadock B, Sadock V, Ruiz P (eds). Comprehensive textbook of psychiatry (Kaplan & Sadock’s). Baltimore: Lippincott Williams & Wilkins, 2017:1445-56.